Masimo Corporation (MASI)
Masimo (MASI) Q2 Earnings Beat Estimates, Gross Margin Up
Strength in Healthcare revenues drive Masimo's (MASI) second-quarter results.
Masimo Corporation (MASI) Q2 2024 Earnings Call Transcript
Masimo Corporation (NASDAQ:MASI ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Eli Kammerman - VP of Business Development & IR Joe Kiani - Chairman & CEO Micah Young - EVP & CFO Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to Masimo's Second Quarter 2024 Earnings Conference call. The company's press release is available at www.masimo.com.
Compared to Estimates, Masimo (MASI) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Masimo (MASI) Tops Q2 Earnings and Revenue Estimates
Masimo (MASI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.62 per share a year ago.
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
Masimo's (MASI) R&D activities raise optimism about the stock.
Masimo (MASI) Sues Politan for Misstatements, Delays Annual Meet
Masimo (MASI) sues Politan to correct material misstatements in an ongoing proxy battle, rescheduling its annual meeting. Politan denies allegations and vows to prevent any further delay, criticizing Masimo's tactics.
Masimo initiates legal action against activist investor Politan
Medical device maker Masimo Corp on Tuesday said it has started litigation against Politan Capital in a California federal court, seeking to force the activist investor to correct "material misstatements and omissions" in its proxy materials.
Proxy advisor ISS says Masimo change is 'absolutely necessary' in brutal report
Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary." The unusually sharp report, a copy of which was viewed by CNBC, said shareholders should vote for activist Politan Capital Management's board nominees, Bill Jellison and Darlene Solomon.
Proxy advisor backs activist Politan nominees in scathing Masimo report
Proxy advisory firm Glass Lewis said Masimo shareholders should vote for activist Politan nominees Darlene Solomon and Bill Jellison. The advisory firm said that Masimo CEO Joe Kiani ran "roughshod" over his "self-selected board," echoing concerns from the activist and some analysts.
Masimo (MASI) Gets Non-Binding Offer for Consumer Business
Masimo (MASI) gets an acquisition offer for its consumer business from an undisclosed entity. The deal is likely to close later in 2024.
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
Masimo's (MASI) second-quarter 2024 results are likely to reflect the strength in the Healthcare business.
Masimo receives offer of up to $950 mln for consumer business
Masimo said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products.
